Jeff Yass’s NanoViricides NNVC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$70.4K Buy
+51,000
New +$69.9K ﹤0.01% 12687
2026
Q1
Sell
-13,100
Closed -$14.8K 13809
2025
Q4
$14.8K Buy
+13,100
New +$18.4K ﹤0.01% 12009
2025
Q3
Sell
-38,000
Closed -$53.2K 13414
2025
Q2
$53.2K Buy
38,000
+23,200
+157% +$31.7K ﹤0.01% 12089
2025
Q1
$17.3K Buy
+14,800
New +$18.8K ﹤0.01% 12149
2024
Q3
Sell
-18,700
Closed -$32.2K 12685
2024
Q2
$32.2K Buy
+18,700
New +$33.3K ﹤0.01% 11545
2024
Q1
Sell
-15,600
Closed -$15.9K 12957
2023
Q4
$15.9K Buy
15,600
+2,500
+19% +$2.89K ﹤0.01% 12011
2023
Q3
$17.6K Buy
+13,100
New +$18.5K ﹤0.01% 11633
2023
Q1
Sell
-18,400
Closed -$20.4K 13180
2022
Q4
$20.4K Sell
18,400
-3,500
-16% -$5.46K ﹤0.01% 11756
2022
Q3
$38K Buy
21,900
+10,100
+86% +$22K ﹤0.01% 12354
2022
Q2
$22K Sell
11,800
-3,700
-24% -$6.8K ﹤0.01% 12344
2022
Q1
$32K Sell
15,500
-34,700
-69% -$81.1K ﹤0.01% 12485
2021
Q4
$187K Sell
50,200
-400
-0.8% -$1.82K ﹤0.01% 11521
2021
Q3
$235K Buy
+50,600
New +$211K ﹤0.01% 11139
2021
Q2
Sell
-13,200
Closed -$62K 13024
2021
Q1
$62K Buy
+13,200
New +$59.7K ﹤0.01% 11991
2014
Q4
Sell
-4,850
Closed -$291K 9946
2014
Q3
$291K Sell
4,850
-7,185
-60% -$564K ﹤0.01% 8076
2014
Q2
$1.02M Buy
12,035
+3,680
+44% +$261K ﹤0.01% 6014
2014
Q1
$535K Buy
+8,355
New +$714K ﹤0.01% 6618

Other funds holding NNVC

Jeff Yass's NNVC Position: Q2 2026 in Review

Jeff Yass reduced its NanoViricides (NNVC) stake by 39% in Q2 2026, selling an estimated $52.7K and leaving 60,616 shares worth $83.7K. The position accounts for ﹤0.01% of the portfolio, ranked #12611.

Jeff Yass first reported a position in NNVC in Q1 2014 and has held it in 27 quarters since. The position peaked at $514K in Q1 2014. 48 funds tracked by Wall St. Rank hold NNVC as of Q2 2026.

  • Jeff Yass held 60,616 shares of NanoViricides worth $83.7K as of Q2 2026.
  • Jeff Yass sold 38,415 NanoViricides shares in Q2 2026, an estimated $52.7K.
  • NanoViricides made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #12611 holding.
  • Jeff Yass first reported a position in NanoViricides in Q1 2014 and has held it in 27 quarters since.
  • Jeff Yass's NanoViricides position peaked at $514K in Q1 2014.
  • 48 funds tracked by Wall St. Rank held NanoViricides as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.